Sedative and Hypnotics Flashcards
SEDATIVES – reduce ______ and exert a ______ effect
HYPNOTICS - produces ______ and facilitates the onset and maintenance of _________________
anxiety; calming
drowsiness ;a state of sleep.
SEDATIVE/HYPNOTICS ANXIOLYTICS
Major therapeutic use is to relief _______(_______) or induce _______(_______)
anxiety (anxiolytics)
sleep (hypnotics).
Hypnotic effects can be achieved with most anxiolytic drugs
T/F
T
just by increasing the dose.
The distinction between a “pathological” and “normal” state of anxiety is easy to draw
T/F
F
hard
anxiolytics are among the most prescribed substances worldwide.
T/F
T
Manifestations of anxiety:
Verbal complaints. The patient says he/she is __________________
Somatic and autonomic effects: . The patient is _______ and _______, has ______cardia, _____eased sweating, weeping and often gastrointestinal disorders.
Social effects. Interference with _________________ activities.
anxious, nervous, edgy.
restless and agitated; tachycardia, incr
Normal productive
Pathological Anxiety
Generalized anxiety disorder (GAD): People suffering from GAD have general symptoms of ————, autonomic ______, etc. for at least ________
motor tension; hyperactivity
one month.
Pathological Anxiety
Phobic anxiety:
Simple phobias. Agoraphobia, fear of ______, etc. Social phobias.
.
animals
Pathological Anxiety
Panic disorders: Characterized by (acute or chronic ?) attacks of ___ as compared to the (acute or chronic?) presentation of GAD.
Acute ; fear
Chronic
Pathological Anxiety
Obsessive-compulsive behaviors: These patients show _________(obsessions) and ___________ (compulsions).
repetitive ideas
behaviors
Causes of Anxiety
______
_____-induced
Drug ______
Medical
Drug-induced
Drug withdrawal
Causes of Anxiety
1). Medical:
Respiratory Endocrine Cardiovascular Metabolic Neurologic.
T/F
T
Causes of Anxiety
2). Drug-Induced:
– Stimulants
_____,_______,_______,_______.
– Sympathomimetics
_______,________,______,________.
– Anticholinergics\Antihistaminergics
________,________,__________,_________
– Dopaminergics
________,________,________,__________
Miscellaneous:
• Baclofen, cycloserine, hallucinogens, indomethacin.
Amphetamines, cocaine, TCAs, caffeine
Ephedrine, epinephrine, pseudoephedrine phenylpropanolamine
Trihexyphenidyl, benztropine, meperidine diphenhydramine, oxybutinin.
Amantadine, bromocriptine, L-Dopa, carbid/levodopa.
Causes of Anxiety
Drug Withdrawal:
•____,________,_________, other ______,______
BDZs, narcotics, BARBs
sedatives, alcohol.
Strategy for treatment of anxiety
_______ anxiety without causing ________.
Reduce
sedation
Anxiolytics
Barbiturates e.g. ________,______,______,_____,_______
Benzodiazepines e.g._______ (Valium), _____ (Versed),_______ (Klonopin) ; ________ (Ormodon), ________ (Rohypnol)
Glutethimide : ____________
Methohexitone, Phenobarbital, Pentabarbital, Thiopentone,Thiamylal
Diazepam; Midazolam; Clonazepam
Nitrazepam; Flunitrazepam
Piperidinediones
Anxiolytics
Meprobamate : __________ _______
Alcohols : ______,_________,_________
Buspirone : _________
Zolpidem : _____________
Zaleplon : __________
Propanediol carbamates
Ethanol, Chloral hydrate, Paraldehyde
Azaspirodecanedione; Imidazopyridine
Pyrazolopyrimidine
BARBITURATES
Derivatives of ___________
–Hypnotic/anxiolytic effect discovered in the early 20th century (Veronal®, 1903)
– Until the 60s, it was the largest group of _________
– (low or high?) risk of dependence ((mild or severe?) withdrawal symptoms)
barbituric acid
hypnotics; high ; severe
BARBITURATES
– (mild or Strong?) depressant activity on the CNS => ________
– At higher doses it causes respiratory and cardiovascular ________ => very little use today as _______ (only for _______ and ________)
Strong ; anesthesia
hypnotics
epilepsy and anesthesia
Structure-Activity Relationship of Barbiturates
The ________ and ______ forms of barbituric acid with the sites of substitution in the hypnotically active barbiturates
keto and enol tautomeric
Structure-Activity Relationship of Barbiturates
Substitution at carbon 5 = *_____ activity is introduced
_______ chain >- greater hypnotic activity
______ group (like ________) -> Greater anticonvulsant activity
Presence of ______philic groups decreases lipophilicity so decreases activity
Hypnotic; Branched
Phenol; phenobarbital
hydro
Benzodiazepines
_____,_______,_______,_____, and _________ properties.
Treatment : _______
At low doses are useful _______ and high doses produce a ________ effect
sedative, hypnotic, anti-anxiety, anticonvulsant, and muscle relaxant
anxiety; sedatives; hypnotic
Benzodiazepines
Absorption and distribution: ___philic, are (slowly or rapidly?) and (completely or incompletely?) absorbed after _____ administration and distribute throughout the body.
Excreted in the urine as ________ or ______ metabolites.
lipo; rapidly ; completely
oral
glucuronides; oxidized
Benzodiazepines
Treatment : anxiety
It has (more or less?) side effects, dependence
It is (more or less?) effective
Less
More
What are the different types of benzodiazepines?
Several types with differences in potency, speed at which they are metabolized, and “half-life” and therapeutic use.
Vary mostly in their ________
duration of action
Benzodiazepines
A substituent in the position _____, such as a _______, or ________ group, is required for sedative-hypnotic activity
7
halogen or a nitro
benzodiazepines
List 4
Clonazepam
Diazepam
Lorazepam
Flunitrazepam
Anxiolytics
_______ (BZDs).
___________ (BARBs).
_________ receptor agonists.
_____,______, and ______ receptor
antagonists.
If ANS symptoms are prominent:
_______________ antagonists.
_________ agonists (clonidine).
Benzodiazepines (BZDs).
Barbiturates (BARBs).
5-HT1A receptor agonists.
5-HT2A, 5-HT2C & 5-HT3 receptor
antagonists.
ß-Adrenoreceptor
Alpha2-AR
Anxiolytics
Other Drugs with anxiolytic activity.
–_____(_______). Used for Obsessive compulsive Disorder.
–________. Used in panic attacks.
– Anti_____ agents. Present in over the counter medications.
– Anti________ (Ziprasidone).
TCAs (Fluvoxamine)
MAOIs; histaminic
psychotics
Anxiolytics
Other Drugs with anxiolytic activity.
Novel drugs. (Most of these are still on clinical trials).
-_____ (e.g. CCK4).
–______/_______ (e.g. HA966).
CCKB
EAA’s/NMDA
Anxiolytics
Other Drugs with anxiolytic activity.
– TCAs (Fluvoxamine). Used for ________________
– MAOIs. Used in _______
Obsessive compulsive Disorder.
panic attacks.
Sedative/Hypnotics
A hypnotic should produce, as much as possible, a state of _____ that resembles _______
sleep
normal sleep.
Sedative/Hypnosis
By definition all sedative/hypnotics will induce sleep at _____ doses.
Normal sleep consists of distinct stages, based on three physiologic measures: ____________gram, ______gram, ____________gram.
high
electroencephalo; electromyo
electronystagmo
Sedative/Hypnosis
Two distinct phases are distinguished which occur cyclically over —— min:
1)___________(NREM). _____% of total sleep. Has _____ stages. Most sleep leads to stage ____.
2)__________ (REM). Recalled _____.
90
Non-rapid eye movement
70-75; 4; 2
Rapid eye movement; dreams
Properties of Sedative/Hypnotics in Sleep
1) The _______ of sleep onset is ____eased (time to ______).
2) The duration of stage ___ ——— sleep is increased.
3) The duration of _____ sleep is decreased.
4) The duration of ___-wave sleep is decreased.
Tolerance occurs after ______
latency; Decr; fall asleep
2 NREM; REM
slow; 1-2 weeks
slow-wave sleep , when ____________ and —————- occur
somnambulism and nightmares
Other Properties of Sedative/Hypnotics
Some sedative/hypnotics will depress the CNS to stage ______ of anesthesia.
Due to their (slow or fast?) onset of action and (short or long?) duration, barbiturates such as _______ and ________ are used as _____ in general anesthesia.
III ; fast ; short
thiopental and methohexital
adjuncts
Sedative/Hypnotics
All of the anxiolytics/sedative/hypnotics should be used only for __________
*****
All the drugs used alter the normal _____ and should be administered only for _______________, never for _________.
************ USE FOR \_\_\_\_\_\_\_-TERM TREATMENT ONLY!!
symptomatic relief.
sleep cycle
days or weeks; months
SHORT
Barbiturates
Long acting
___________
Short acting
___________ , ___________
Ultra-short acting
___________
___________
Phenobarbitone
Butobarbitone ,Pentobarbitone
Thiopentone
Methohexitone
Benzodiazepines
Hypnotic
List 6
Antianxiety
List 5
Anticonvulsant
List 4
Diazepam Flurazepam Nitrazepam Alprazolam Temazepam Triazolam
Diazepam Chlordiazepoxide
Oxazepam Lorazepam Alprazolam
Diazepam Lorazepam
Clonazepam Clobazam
Non Benzodiazepine hypnotics
List 3
Miscellaneous
List 2
ZOLPIDEM
ZALEPLON
ZOPICLONE (ESZOPICLONE)
MELATONIN RAMELTEON
GABA-A Receptor
Major player in ______ Synapses.
It is a ____ Channel.
Binding of GABA causes the channel to ____ and ____ to flow ____ the cell with the resultant membrane _____________.
Inhibitory
Cl- ; open
Cl- ; into
hyperpolarization
GABA Receptor
Increase in Cl− permeability can depolarize the target cell under some conditions of ________________. This in turn potentially can _____________ or to activate _______ via voltage-gated channels and has been proposed as a physiologically relevant event, especially in embryonic neurons.
high intracellular Cl−
excite the cell to fire
Ca2+ entry